SPARC MICROENVIRONMENT SIGNATURE (SMS) Trademark

Trademark Overview

On Wednesday, August 21, 2013, a trademark application was filed for SPARC MICROENVIRONMENT SIGNATURE (SMS) with the United States Patent and Trademark Office. The USPTO has given the SPARC MICROENVIRONMENT SIGNATURE (SMS) trademark a serial number of 86043850. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Monday, April 20, 2020. This trademark is owned by Abraxis Bioscience, LLC. The SPARC MICROENVIRONMENT SIGNATURE (SMS) trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

providing medical diagnostic testing and analysis to determine appropriate therapy; medical and pharmaceutical information services in the field of cancer; medical and pharmaceutical consultation services in the field of cancer; medical information and medical consultation
sparc microenvironment signature (sms)

General Information

Serial Number86043850
Word MarkSPARC MICROENVIRONMENT SIGNATURE (SMS)
Filing DateWednesday, August 21, 2013
Status711 - CANCELLED - SECTION 7
Status DateMonday, April 20, 2020
Registration Number4489844
Registration DateTuesday, February 25, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"MICROENVIRONMENT SIGNATURE"
Goods and Servicesproviding medical diagnostic testing and analysis to determine appropriate therapy; medical and pharmaceutical information services in the field of cancer; medical and pharmaceutical consultation services in the field of cancer; medical information and medical consultation

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateMonday, April 20, 2020
Primary Code044
First Use Anywhere DateFriday, June 4, 2010
First Use In Commerce DateFriday, June 4, 2010

Trademark Owner History

Party NameAbraxis Bioscience, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSummit, NJ 07901
Party NameAbraxis Bioscience, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLos Angeles, CA 90025

Trademark Events

Event DateEvent Description
Tuesday, April 21, 2020NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Monday, April 20, 2020CANCELLED SECTION 7-TOTAL
Tuesday, February 11, 2020REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Monday, March 30, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 11, 2020TEAS SECTION 7 SURRENDER RECEIVED
Monday, February 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 25, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 25, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 25, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 25, 2014REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, January 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 21, 2014ASSIGNED TO LIE
Wednesday, December 25, 2013APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, December 23, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 23, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 7, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 7, 2013NON-FINAL ACTION E-MAILED
Saturday, December 7, 2013NON-FINAL ACTION WRITTEN
Friday, December 6, 2013ASSIGNED TO EXAMINER
Thursday, August 29, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 24, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

signature microenvironment sparc medical services information field cancer consultation pharmaceutical appropriate testing diagnostic